Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3225847)

Published in MAbs on September 01, 2011

Authors

Imre Kacskovics1, Judit Cervenak, Anna Erdei, Richard A Goldsby, John E Butler

Author Affiliations

1: ImmunoGenes Ltd., Budakeszi, Hungary. kacskovics@immunogenes.com

Articles citing this

IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 1.95

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov (2012) 1.62

Characterization and screening of IgG binding to the neonatal Fc receptor. MAbs (2014) 0.93

Characterization of the rabbit neonatal Fc receptor (FcRn) and analyzing the immunophenotype of the transgenic rabbits that overexpresses FcRn. PLoS One (2012) 0.90

FcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodies. PLoS One (2012) 0.86

Regulation of immune responses by the neonatal fc receptor and its therapeutic implications. Front Immunol (2015) 0.85

NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn. MAbs (2014) 0.84

A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life. MAbs (2015) 0.81

Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor. Front Immunol (2016) 0.77

Linkage haplotype for allotypic variants of porcine IgA and IgG subclass genes. Immunogenetics (2012) 0.77

Targeting FcRn for therapy: from live cell imaging to in vivo studies in mice. Immunol Lett (2014) 0.77

Overexpression of Bovine FcRn in Mice Enhances T-Dependent Immune Responses by Amplifying T Helper Cell Frequency and Germinal Center Enlargement in the Spleen. Front Immunol (2015) 0.76

Articles cited by this

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99

Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26

FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol (2007) 7.94

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98

Metabolism of immunoglobulins. Prog Allergy (1969) 5.74

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature (1996) 5.25

Potent antibody therapeutics by design. Nat Rev Immunol (2006) 4.87

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72

An Fc receptor structurally related to MHC class I antigens. Nature (1989) 4.32

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89

THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med (1965) 3.87

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A (1996) 3.37

A THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM. Nature (1964) 3.31

The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol (2003) 3.09

A microengraving method for rapid selection of single cells producing antigen-specific antibodies. Nat Biotechnol (2006) 2.94

Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol (1996) 2.90

The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest (1972) 2.88

FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION. J Exp Med (1963) 2.78

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine (2011) 2.53

Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol (2011) 2.41

Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol (2010) 2.41

MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol (2001) 2.33

Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol (2006) 2.32

THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS. J Clin Invest (1961) 2.32

A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat Med (2009) 2.24

Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol (1985) 2.20

Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol (1998) 2.14

Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol (2002) 2.13

RELATIONSHIP BETWEEN GAMMA-GLOBULIN METABOLISM AND LOW SERUM GAMMA-GLOBULIN IN GERMFREE MICE. J Immunol (1964) 2.05

Receptor-mediated transport of IgG. J Cell Biol (1984) 2.05

Interference by human and bovine serum and serum protein fractions with the absorption of antibodies by suckling rats and mice. Proc R Soc Lond B Biol Sci (1958) 1.99

Early stages of intestinal absorption of specific antibiodies in the newborn. An ultrastructural, cytochemical, and immunological study in the pig, rat, and rabbit. J Cell Biol (1969) 1.86

Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A (2008) 1.82

Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J Immunol (1995) 1.81

Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med (2002) 1.77

Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene. J Virol (1993) 1.76

Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol (2010) 1.50

Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci U S A (2011) 1.44

Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv Immunol (2009) 1.42

Presence of neutrophil-bearing antigen in lymphoid organs of immune mice. Blood (2006) 1.39

CCR7 is involved in the migration of neutrophils to lymph nodes. Blood (2010) 1.34

The generation of memory cells. IV. Immunization with antigen-antibody complexes accelerates the development of B-memory cells, the formation of germinal centres and the maturation of antibody affinity in the secondary response. Immunology (1981) 1.32

Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J Immunol (1997) 1.31

FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood (2006) 1.30

Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice. Eur J Immunol (1985) 1.27

Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol (1998) 1.26

Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice. J Exp Med (2010) 1.25

Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol (2008) 1.20

Early and enhanced germinal center formation and antibody responses in mice after primary stimulation with antigen-isologous antibody complexes as compared with antigen alone. J Immunol (1971) 1.20

NF-kappaB signaling regulates functional expression of the MHC class I-related neonatal Fc receptor for IgG via intronic binding sequences. J Immunol (2007) 1.14

Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. J Immunol (2009) 1.14

Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood (2001) 1.09

How antibodies act as natural adjuvants. Immunol Lett (2005) 1.09

Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur J Immunol (1999) 1.08

GAMMA GLOBULIN TURNOVER IN RABBITS BEFORE AND DURING HYPERIMMUNIZATION. J Exp Med (1964) 1.08

FcRn mediates elongated serum half-life of human IgG in cattle. Int Immunol (2006) 1.03

Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J Immunol (2000) 1.00

The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J Immunol (2011) 0.99

Identification of memory B cells using a novel transgenic mouse model. J Immunol (2006) 0.98

Neonatal FcR overexpression boosts humoral immune response in transgenic mice. J Immunol (2010) 0.97

Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice. Immunology (2007) 0.97

Immune complex-mediated enhancement of secondary antibody responses. J Immunol (2010) 0.97

Cloning and characterization of the bovine MHC class I-like Fc receptor. J Immunol (2000) 0.96

An elegant defense: how neutrophils shape the immune response. Trends Immunol (2009) 0.95

Clinical ramifications of the MHC family Fc receptor FcRn. J Clin Immunol (2010) 0.94

The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal/lysosomal compartments. J Immunol (2008) 0.94

Position independent and copy-number-related expression of the bovine neonatal Fc receptor alpha-chain in transgenic mice carrying a 102 kb BAC genomic fragment. Transgenic Res (2007) 0.92

FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen. MAbs (2011) 0.89

Redistribution of the sheep neonatal Fc receptor in the mammary gland around the time of parturition in ewes and its localization in the small intestine of neonatal lambs. Immunology (2002) 0.88

The neonatal Fc receptor (FcRn) is expressed in the bovine lung. Vet Immunol Immunopathol (2004) 0.86

Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity. Immunol Lett (2011) 0.85

Development of antibody-targeted vaccines. Curr Opin Mol Ther (2005) 0.81

Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice. Rheumatology (Oxford) (2010) 0.80

Evaluation of Bcl-2/B cell transgenic mice (B6) for hybridoma production. Hybridoma (1996) 0.78

Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia. AAPS J (2006) 0.77

Improved generation of catalytic antibodies by MRL/MPJ-lpr/lpr autoimmune mice. J Immunol Methods (2000) 0.76

Articles by these authors

Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol (2002) 2.13

Phosphorylation adjacent to the nuclear localization signal of human dUTPase abolishes nuclear import: structural and mechanistic insights. Acta Crystallogr D Biol Crystallogr (2013) 2.03

Antigen microarrays: descriptive chemistry or functional immunomics? Trends Immunol (2010) 1.53

C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol (2004) 1.48

Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol Immunol (2004) 1.32

Identification of IgF, a hinge-region-containing Ig class, and IgD in Xenopus tropicalis. Proc Natl Acad Sci U S A (2006) 1.29

Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J Neuroimmunol (2004) 1.29

Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface. J Biol Chem (2004) 1.19

Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J Immunol (2004) 1.10

Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol Lett (2005) 1.08

Complement protein C1q induces maturation of human dendritic cells. Mol Immunol (2007) 1.06

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol Dis (2004) 1.04

Lymphoid hyperplasia resulting in immune dysregulation is caused by porcine reproductive and respiratory syndrome virus infection in neonatal pigs. J Immunol (2004) 1.04

FcRn mediates elongated serum half-life of human IgG in cattle. Int Immunol (2006) 1.03

The ontogeny of the porcine immune system. Dev Comp Immunol (2008) 1.02

B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity. Mol Immunol (2008) 1.01

Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway. J Immunol (2003) 1.00

Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies. Infect Immun (2010) 0.99

Neonatal FcR overexpression boosts humoral immune response in transgenic mice. J Immunol (2010) 0.97

Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol (2003) 0.97

Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients. Int Immunol (2008) 0.97

DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken. J Cell Biol (2010) 0.96

Antibody repertoire development in fetal and neonatal piglets. XI. The relationship of variable heavy chain gene usage and the genomic organization of the variable heavy chain locus. J Immunol (2010) 0.95

High efficiency creation of human monoclonal antibody-producing hybridomas. J Immunol Methods (2004) 0.94

Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes. J Immunol (2002) 0.93

The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol (2006) 0.93

dUTPase and nucleocapsid polypeptides of the Mason-Pfizer monkey virus form a fusion protein in the virion with homotrimeric organization and low catalytic efficiency. J Biol Chem (2003) 0.90

Characterization of the rabbit neonatal Fc receptor (FcRn) and analyzing the immunophenotype of the transgenic rabbits that overexpresses FcRn. PLoS One (2012) 0.90

FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen. MAbs (2011) 0.89

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. Int Immunol (2012) 0.88

Antibody repertoire development in fetal and neonatal piglets. VI. B cell lymphogenesis occurs at multiple sites with differences in the frequency of in-frame rearrangements. J Immunol (2003) 0.88

The little brown bat, M. lucifugus, displays a highly diverse V H, D H and J H repertoire but little evidence of somatic hypermutation. Dev Comp Immunol (2010) 0.87

Bone marrow-derived mast cell differentiation is strongly reduced in histidine decarboxylase knockout, histamine-free mice. Int Immunol (2002) 0.87

Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies. FEBS Lett (2006) 0.87

Developmental regulation of dUTPase in Drosophila melanogaster. J Biol Chem (2004) 0.87

Lymphocyte development in fetal piglets: facts and surprises. Vet Immunol Immunopathol (2005) 0.86

Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1/2. Immunol Lett (2008) 0.86

CR3 is the dominant phagocytotic complement receptor on human dendritic cells. Immunobiology (2012) 0.86

FcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodies. PLoS One (2012) 0.86

Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One (2011) 0.86

Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. J Allergy Clin Immunol (2005) 0.86

Genomic organization of the immunoglobulin light chain gene loci in Xenopus tropicalis: evolutionary implications. Dev Comp Immunol (2007) 0.85

Antibody repertoire development in fetal and neonatal piglets. XII. Three IGLV genes comprise 70% of the pre-immune repertoire and there is little junctional diversity. Mol Immunol (2013) 0.85

A novel fruitfly protein under developmental control degrades uracil-DNA. Biochem Biophys Res Commun (2007) 0.85

Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity. Immunol Lett (2011) 0.85

Ileal Peyer's patches are not necessary for systemic B cell development and maintenance and do not contribute significantly to the overall B cell pool in swine. J Immunol (2011) 0.84

On-chip complement activation adds an extra dimension to antigen microarrays. Mol Cell Proteomics (2006) 0.84

IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination. Clin Vaccine Immunol (2010) 0.84

Association of RNA with the uracil-DNA-degrading factor has major conformational effects and is potentially involved in protein folding. FEBS J (2010) 0.84

Cellular response to efficient dUTPase RNAi silencing in stable HeLa cell lines perturbs expression levels of genes involved in thymidylate metabolism. Nucleosides Nucleotides Nucleic Acids (2011) 0.83

Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells. Hum Gene Ther (2003) 0.83

A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes. Mol Immunol (2009) 0.83

Impact of molecular mimicry on the clinical course and outcome of sepsis syndrome. Mol Immunol (2011) 0.83

B cell development and VDJ rearrangement in the fetal pig. Vet Immunol Immunopathol (2002) 0.83

The role of CR2 in autoimmunity. Autoimmunity (2006) 0.82

The beta subunit of the type I Fcepsilon receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells. J Immunol (2005) 0.82

An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes. Immunol Lett (2008) 0.82

FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene. Eur J Hum Genet (2005) 0.82

Haemophilus parasuis exhibits IgA protease activity but lacks homologs of the IgA protease genes of Haemophilus influenzae. Vet Microbiol (2011) 0.81

Structure of the genomic sequence comprising the immunoglobulin heavy constant (IGHC) genes from Sus scrofa. Mol Immunol (2012) 0.81

Cloning, expression and characterization of the bovine p65 subunit of NFkappaB. Dev Comp Immunol (2007) 0.81

Modulation of immune response by combined targeting of complement receptors and low-affinity Fcgamma receptors. Immunol Lett (2009) 0.81

Transgenic rabbits that overexpress the neonatal Fc receptor (FcRn) generate higher quantities and improved qualities of anti-thymocyte globulin (ATG). PLoS One (2013) 0.80

Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice. Rheumatology (Oxford) (2010) 0.80

Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen. Int Immunol (2002) 0.79

Novel roles for murine complement receptors type 1 and 2 II. Expression and function of CR1/2 on murine mesenteric lymph node T cells. Immunol Lett (2008) 0.79

Antibody repertoire development in fetal and neonatal piglets. XXII. λ Rearrangement precedes κ rearrangement during B-cell lymphogenesis in swine. Immunology (2012) 0.79

Prenatal development of the porcine TCR delta repertoire: dominant expression of an invariant T cell receptor Vdelta3-Jdelta3 chain. Eur J Immunol (2004) 0.79

Detection of complement activation on antigen microarrays generates functional antibody profiles and helps characterization of disease-associated changes of the antibody repertoire. J Immunol (2008) 0.79

Antibody repertoire development in fetal and neonatal piglets. XV. Porcine circovirus type 2 infection differentially affects serum IgG levels and antibodies to ORF2 in piglets free from other environmental factors. Vaccine (2012) 0.78

Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production. Mol Immunol (2009) 0.78

Elimination of autoreactive B cells in humanized SCID mouse model of SLE. Eur J Immunol (2011) 0.78

Altered expression of Fcgamma and complement receptors on B cells in systemic lupus erythematosus. Ann N Y Acad Sci (2007) 0.78

Syk is indispensable for CpG-induced activation and differentiation of human B cells. Cell Mol Life Sci (2014) 0.78

Targeting with scFv: immune modulation by complement receptor specific constructs. J Mol Recognit (2003) 0.77

Mucosal type mast cells express complement receptor type 2 (CD21). Immunol Lett (2002) 0.77

Two-dimensional immune profiles improve antigen microarray-based characterization of humoral immunity. Proteomics (2008) 0.77

DNA-containing extracellular 50-nm particles in the ileal Peyer's patch of sheep. Eur J Cell Biol (2002) 0.77

Antibody repertoire development in fetal and neonatal piglets. XI. The thymic B-cell repertoire develops independently from that in blood and mesenteric lymph nodes. Immunology (2005) 0.76

C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells. Int Immunol (2008) 0.76

Murine CR1/2 targeted antigenized single-chain antibody fragments induce transient low affinity antibodies and negatively influence an ongoing immune response. Adv Exp Med Biol (2007) 0.76

Human T cell derived, cell-bound complement iC3b is integrally involved in T cell activation. Immunol Lett (2012) 0.76

Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays. J Immunol Methods (2011) 0.76

Set a thief to catch a thief: self-reactive innate lymphocytes and self tolerance. Autoimmun Rev (2007) 0.75

Intestinal resection and anastomosis in neonatal gnotobiotic piglets. J Am Assoc Lab Anim Sci (2011) 0.75

Mathematical analysis of clinical data reveals a homunculus of bacterial mimotopes protecting from autoimmunity via oral tolerance in human. Mol Immunol (2009) 0.75

Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro. PLoS One (2015) 0.75

Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases. Hum Gene Ther Methods (2012) 0.75

The comparative profile of lymphoid cells and the T and B cell spectratype of germ-free piglets infected with viruses SIV, PRRSV or PCV2. Vet Res (2014) 0.75

The role of the complement system in the pathogenesis of experimental autoimmune encephalomyelitis and multiple sclerosis. Adv Exp Med Biol (2006) 0.75

Volatile glycosides from the leaves of Morus alba with a potential contribution to the complex anti-diabetic activity. Nat Prod Commun (2014) 0.75

EFIS: driving women's representation in immunology in Europe. Eur J Immunol (2014) 0.75

Modulation of the humoral immune response by targeting CD40 and FcγRII/III; delivery of soluble but not particulate antigen to CD40 enhances antibody responses with a Th1 bias. Mol Immunol (2011) 0.75